Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate

References

• Hogg N, Palmer DG, Revell PA. Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies. Immunology. 1985;56:673–681.
   PubMed Web of Science ®Google Scholar
• Demaziere A. [Macrophages in rheumatoid synovial membrane: an update]. Rev Rhum Ed Fr. 1993;60:568–579.
   PubMedGoogle Scholar
• Tak PP, Smeets TJ, Daha MR, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997;40:217–225.
   PubMed Web of Science ®Google Scholar
• Youssef P, Roth J, Frosch M, et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol. 1999;26:2523–2528.
   PubMed Web of Science ®Google Scholar
• Brown AK, Conaghan PG, Karim Z, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958–2967.
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68:1–26.
   PubMed Web of Science ®Google Scholar
• O’Dell JR. Methotrexate use in rheumatoid arthritis. Rheum Dis Clin North Am. 1997;23:779–796.
   PubMed Web of Science ®Google Scholar
• Bannwarth B, Pehourcq F, Schaeverbeke T, et al. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet. 1996;30:194–210.
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Kaplan H, Germain BF, et al. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum. 1994;37:1492–1498.
   PubMed Web of Science ®Google Scholar
• Patro PS, Singh A, Misra R, et al. Myeloid-related protein 8/14 levels in rheumatoid arthritis: marker of disease activity and response to methotrexate. J Rheumatol. 2016;43:731–737.
   PubMed Web of Science ®Google Scholar
• Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60:540–551.
   PubMed Web of Science ®Google Scholar
• Viemann D, Strey A, Janning A, et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood. 2005;105:2955–2962.
   PubMed Web of Science ®Google Scholar
• Newton RA, Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol. 1998;160:1427–1435.
   PubMed Web of Science ®Google Scholar
• Rammes A, Roth J, Goebeler M, et al. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem. 1997;272:9496–9502.
   PubMed Web of Science ®Google Scholar
• Haga HJ, Brun JG, Berntzen HB, et al. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus. 1993;2:47–50.
   PubMed Web of Science ®Google Scholar
• Brun JG, Haga HJ, Boe E, et al. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol. 1992;19:859–862.
   PubMed Web of Science ®Google Scholar
• Hammer HB, Kvien TK, Glennas A, et al. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin Exp Rheumatol. 1995;13:59–64.
   PubMed Web of Science ®Google Scholar
• Frosch M, Vogl T, Seeliger S, et al. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2003;48:2622–2626.
   PubMed Web of Science ®Google Scholar
• Frosch M, Strey A, Vogl T, et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000;43:628–637.
   PubMed Web of Science ®Google Scholar
• Baillet A. [S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis]. Rev Med Interne. 2010;31:458–461.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Hellstrom PM, Fagerhol MK, et al. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2005;2:96–102.
   Web of Science ®Google Scholar
• Abildtrup M, Kingsley GH, Scott DL. Calprotectin as a biomarker for rheumatoid arthritis: a systematic review. J Rheumatol. 2015;42:760–770.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.
   PubMed Web of Science ®Google Scholar
• van Riel PLCM, Fransen J, Scott DL. EULAR handbook of clinical assessments in rheumatoid arthritis. Van Zuiden Communications B.V. 2004.
   Google Scholar
• Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38:727–735.
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh). 1977;18:481–491.
   PubMed Web of Science ®Google Scholar
• Bruhn LV, Lauridsen KG, Schmidt AS, et al. Elevated calprotectin in patients with atrial fibrillation with and without heart failure. Scand J Clin Lab Invest. 2017;77:210–215.
   PubMed Web of Science ®Google Scholar
• Andres Cerezo L, Mann H, Pecha O, et al. Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther. 2011;13:R122.
   PubMed Web of Science ®Google Scholar
• Hammer HB, Haavardsholm EA, Kvien TK. Calprotectin (a major leucocyte protein) is associated with the levels of anti-CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis. Scand J Rheumatol. 2008;37:179–182.
   PubMed Web of Science ®Google Scholar
• Garcia-Arias M, Pascual-Salcedo D, Ramiro S, et al. Calprotectin in rheumatoid arthritis: association with disease activity in a cross-sectional and a longitudinal cohort. Mol Diagn Ther. 2013;17:49–56.
   PubMed Web of Science ®Google Scholar
• Choi IY, Gerlag DM, Herenius MJ, et al. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis. 2015;74:499–505.
   PubMed Web of Science ®Google Scholar
• Hammer HB, Fagerhol MK, Wien TN, et al. The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab. Arthritis Res Ther. 2011;13:R178.
   PubMed Web of Science ®Google Scholar
• Nordal HH, Brokstad KA, Solheim M, et al. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. Arthritis Res Ther. 2017;19:3.
   PubMed Web of Science ®Google Scholar
• Hammer HB, Odegard S, Fagerhol MK, et al. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis. 2007;66:1093–1097.
   PubMed Web of Science ®Google Scholar
• Berntzen HB, Olmez U, Fagerhol MK, et al. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 1991;20:74–82.
   PubMed Web of Science ®Google Scholar
• de Seny D, Fillet M, Ribbens C, et al. Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin Chem. 2008;54:1066–1075.
   PubMed Web of Science ®Google Scholar
• Hurnakova J, Zavada J, Hanova P, et al. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Res Ther. 2015;17:252.
   PubMed Web of Science ®Google Scholar
• Hammer HB, Odegard S, Syversen SW, et al. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69:150–154.
   PubMed Web of Science ®Google Scholar
• Theede K, Kiszka-Kanowitz M, Nielsen AM, et al. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment. Scand J Gastroenterol. 2014;49:418–423.
   PubMed Web of Science ®Google Scholar
• Ertugrul AS, Sahin H. The effect of smoking on myeloid-related protein-8 and myeloid-related protein-14. Braz Oral Res. 2016. DOI: 10.1590/1807-3107BOR-2016.vol30.0051
   PubMed Web of Science ®Google Scholar
• Madland TM, Hordvik M, Haga HJ, et al. Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A Longitudinal Study. Scand J Rheumatol. 2002;31:351–354.
   PubMed Web of Science ®Google Scholar
• Berntzen HB, Munthe E, Fagerhol MK. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol. 1989;16:1416–1420.
   PubMed Web of Science ®Google Scholar
• Berntzen HB, Fagerhol MK, Ostensen M, et al. The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. J Rheumatol. 1991;18:133–138.
   PubMed Web of Science ®Google Scholar